Literature DB >> 14758439

Smallpox and bioterrorism.

Hugh Pennington1.   

Abstract

Smallpox was declared to be eradicated on 8 May 1980, during the Thirty-third World Health Assembly. However, concerns about the possible use of the virus as a weapon of bioterrorism have increased in recent years. Governments have responded by initiating selective vaccination programmes and other public health measures. This review uses historical data from 20th century outbreaks to assess the risks to current populations (which have declining immunity) from a deliberate release of virus. The data presented supports the conclusion of a previous reviewer (Mack) that "smallpox cannot be said to live up to its reputation. Far from being a quick-footed menace, it has appeared as a plodding nuisance with more bark than bite." Its R value (the average number of secondary cases infected by a primary case) is lower than that for measles, human parvovirus, chickenpox, mumps, rubella, and poliomyelitis; only the value for severe acute respiratory syndrome (SARS) is lower. Like SARS, close person-to-person contact is required for effective spread of the disease, and exposure to the virus in hospitals has played an important role in transmission for both viruses. In the present paper the dangers of mass vaccination are emphasized, along with the importance of case isolation, contact tracing, and quarantine of close contacts for outbreak control. The need for rapid diagnosis and the continued importance of maintaining a network of electron microscopes for this purpose are also highlighted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14758439      PMCID: PMC2572332     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  14 in total

1.  Evolution, safety, and highly pathogenic influenza viruses.

Authors:  Marc Lipsitch; Joshua B Plotkin; Lone Simonsen; Barry Bloom
Journal:  Science       Date:  2012-06-22       Impact factor: 47.728

Review 2.  Bioterrorism and the Role of the Clinical Microbiology Laboratory.

Authors:  Elizabeth Wagar
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

3.  Free, at last! The progress of new disease eradication campaigns for Guinea worm disease and polio, and the prospect of tackling other diseases.

Authors:  Andrea Rinaldi
Journal:  EMBO Rep       Date:  2009-03       Impact factor: 8.807

4.  Vaccinia virus entry, exit, and interaction with differentiated human airway epithelia.

Authors:  Paola D Vermeer; Julia McHugh; Tatiana Rokhlina; Daniel W Vermeer; Joseph Zabner; Michael J Welsh
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

5.  Low-resolution structure of vaccinia virus DNA replication machinery.

Authors:  Céleste Sèle; Frank Gabel; Irina Gutsche; Ivan Ivanov; Wim P Burmeister; Frédéric Iseni; Nicolas Tarbouriech
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

Review 6.  Orthopoxvirus targets for the development of new antiviral agents.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Antiviral Res       Date:  2012-03-08       Impact factor: 10.103

7.  Australian public and smallpox.

Authors:  David N Durrheim; Reinhold Muller; Vicki Saunders; Rick Speare; John B Lowe
Journal:  Emerg Infect Dis       Date:  2005-11       Impact factor: 6.883

8.  Exploiting human memory B cell heterogeneity for improved vaccine efficacy.

Authors:  Noel T Pauli; Carole J Henry Dunand; Patrick C Wilson
Journal:  Front Immunol       Date:  2011-12-15       Impact factor: 7.561

9.  Smallpox still haunts scientists: results of a questionnaire-based inquiry on the views of health care and life science experts and students on preserving the remaining variola virus stocks.

Authors:  Thangavelu Srinivasan; Vidyasagar Devaprasad Dedeepiya; Sudhakar John; Rajappa Senthilkumar; Helen C Reena; Paramasivam Rajendran; Madasamy Balamurugan; Gene Kurosawa; Masaru Iwasaki; Senthilkumar Preethy; Samuel J K Abraham
Journal:  ScientificWorldJournal       Date:  2013-07-22

10.  Modelling the effects of Wuhan's lockdown during COVID-19, China.

Authors:  Zheming Yuan; Yi Xiao; Zhijun Dai; Jianjun Huang; Zhenhai Zhang; Yuan Chen
Journal:  Bull World Health Organ       Date:  2020-05-28       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.